SMT201300022B - Sospensioni liquide di riluzolo - Google Patents
Sospensioni liquide di riluzoloInfo
- Publication number
- SMT201300022B SMT201300022B SM201300022T SM201300022T SMT201300022B SM T201300022 B SMT201300022 B SM T201300022B SM 201300022 T SM201300022 T SM 201300022T SM 201300022 T SM201300022 T SM 201300022T SM T201300022 B SMT201300022 B SM T201300022B
- Authority
- SM
- San Marino
- Prior art keywords
- riluzolo
- liquid suspensions
- suspensions
- liquid
- Prior art date
Links
- 239000006194 liquid suspension Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09425101A EP2228054A1 (de) | 2009-03-13 | 2009-03-13 | Wässrige Riluzol-Suspensionen |
| EP10706234A EP2405890B1 (de) | 2009-03-13 | 2010-03-02 | Wässrige suspensionen von riluzol |
| PCT/EP2010/052598 WO2010102923A2 (en) | 2009-03-13 | 2010-03-02 | Riluzole aqueous suspensions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT201300022B true SMT201300022B (it) | 2013-03-08 |
Family
ID=40810549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM201300022T SMT201300022B (it) | 2009-03-13 | 2013-02-14 | Sospensioni liquide di riluzolo |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8765150B2 (de) |
| EP (2) | EP2228054A1 (de) |
| JP (1) | JP5607083B2 (de) |
| KR (1) | KR101680175B1 (de) |
| CN (1) | CN102341091B (de) |
| BR (1) | BRPI1006418A2 (de) |
| CA (1) | CA2748856C (de) |
| CL (1) | CL2011002217A1 (de) |
| CO (1) | CO6410281A2 (de) |
| CY (1) | CY1113825T1 (de) |
| DK (1) | DK2405890T3 (de) |
| ES (1) | ES2400349T3 (de) |
| HK (1) | HK1161985A1 (de) |
| HR (1) | HRP20130021T1 (de) |
| MX (1) | MX2011008922A (de) |
| PE (1) | PE20120649A1 (de) |
| PL (1) | PL2405890T3 (de) |
| PT (1) | PT2405890E (de) |
| RU (1) | RU2498802C2 (de) |
| SI (1) | SI2405890T1 (de) |
| SM (1) | SMT201300022B (de) |
| WO (1) | WO2010102923A2 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2849213A1 (en) * | 2011-07-13 | 2013-01-17 | Cytokinetics, Inc. | Combination of riluzole and ck-2017357 for treating als |
| WO2013192610A2 (en) | 2012-06-23 | 2013-12-27 | Fox Chase Chemical Diversity Center, Inc. | Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosis |
| ES2644840T3 (es) * | 2014-11-20 | 2017-11-30 | S.I.I.T. S.R.L.-Servizio Internazionale Imballaggi Termosaldanti | Preparación medicinal a base de diosmectita |
| WO2016081466A1 (en) * | 2014-11-21 | 2016-05-26 | Biohaven Pharmaceutical Holding Company Ltd. | Sublingual administration of riluzole |
| KR102580378B1 (ko) | 2014-11-21 | 2023-09-19 | 바이오하벤 파마슈티컬 홀딩 컴퍼니 엘티디. | 릴루졸의 설하 제제 |
| US11911369B2 (en) * | 2015-03-03 | 2024-02-27 | Biohaven Therapeutics Ltd. | Prodrugs of riluzole and their method of use |
| ITUB20155193A1 (it) * | 2015-11-03 | 2017-05-03 | Italfarmaco Spa | Sospensioni orali di Givinostat fisicamente e chimicamente stabili |
| CN105726477B (zh) * | 2016-03-01 | 2018-10-12 | 山东司邦得制药有限公司 | 一种小儿多潘立酮混悬液及其制备方法 |
| CN108721325B (zh) * | 2017-04-13 | 2020-03-06 | 辽宁大熊制药有限公司 | 蒙脱石混悬液及其制备方法 |
| US20200289476A1 (en) * | 2017-11-28 | 2020-09-17 | University Of Houston System | Liquid formulations of riluzole for oral and intravenous use |
| CN111437256A (zh) * | 2019-01-17 | 2020-07-24 | 北京万全德众医药生物技术有限公司 | 一种利鲁唑缓释口服混悬液 |
| CN115025056A (zh) * | 2022-06-27 | 2022-09-09 | 郑州大学第一附属医院 | 一种含有替加氟、吉莫斯特和奥替拉西钾的口腔崩解制剂 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ288492B6 (en) | 1990-04-24 | 2001-06-13 | Biota Scient Management | Derivatives of alpha-D-neuraminic acid, process of their preparation, their use and pharmaceutical preparations based thereon |
| FR2688138B1 (fr) | 1992-03-06 | 1995-05-05 | Rhone Poulenc Rorer Sa | Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique. |
| AUPN605795A0 (en) * | 1995-10-19 | 1995-11-09 | F.H. Faulding & Co. Limited | Analgesic pharmaceutical composition |
| FR2777781B1 (fr) * | 1998-04-24 | 2004-04-09 | Rhone Poulenc Rorer Sa | Associations riluzole et l-dopa pour le traitement de la maladie de parkinson |
| US7374779B2 (en) * | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
| DE60017733T2 (de) * | 1999-06-04 | 2006-01-12 | Vereniging Voor Christelijk Wetenschappelijk Onderwijs | Verwendung von riluzol zur behandlung multipler sklerose |
| ATE289478T1 (de) * | 1999-08-12 | 2005-03-15 | Lilly Co Eli | Ektoparasitizide wässrige suspensionsformulierungen von spinosynen |
| US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6432992B1 (en) | 2000-06-05 | 2002-08-13 | Aventis Pharm Sa | Use of riluzole or its salts for the prevention and treatment of adrenoleukodystrophy |
| US6613308B2 (en) * | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
| US6861413B2 (en) * | 2001-05-22 | 2005-03-01 | Pfizer Inc. | Stable non-dihydrate azithromycin oral suspensions |
| WO2003084518A2 (fr) | 2002-04-09 | 2003-10-16 | Flamel Technologies | Suspension orale de microcapsules de principes actifs |
| ES2588780T3 (es) | 2002-11-15 | 2016-11-04 | Teva Pharmaceutical Industries Limited | Uso de rasagilina con o sin riluzol para el tratamiento de la esclerosis lateral amiotrófica |
| PT1477166E (pt) | 2003-04-28 | 2006-12-29 | Biofrontera Bioscience Gmbh | Utilização de riluzole combinado com substâncias auxiliares e aditivos adequados, para o tratamento de doenças caracterizadas por uma hiperproliferação de queratinócitos, especialmente de neurodermite e psoríase |
| US9492541B2 (en) | 2004-09-14 | 2016-11-15 | Sovereign Pharmaceuticals, Llc | Phenylepherine containing dosage form |
| US20050266032A1 (en) | 2003-12-17 | 2005-12-01 | Sovereign Pharmaceuticals, Ltd. | Dosage form containing multiple drugs |
| WO2005084377A2 (en) | 2004-03-03 | 2005-09-15 | Teva Pharmaceutical Industries, Ltd. | Combination therapy with glatiramer acetate and riluzole |
| US7691368B2 (en) * | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
| ITMI20061274A1 (it) * | 2006-06-30 | 2008-01-01 | Consiglio Nazionale Ricerche | Vettori nanoparticellari lipidici contenenti riluzolo e composizioni farmaceutiche che li contengono |
| US9132071B2 (en) * | 2006-07-28 | 2015-09-15 | Santen Sas | Compositions containing quaternary ammonium compounds |
| UA41879U (ru) * | 2009-02-03 | 2009-06-10 | Сергей Викторович Фурс | Инфракрасный обогревательный прибор |
-
2009
- 2009-03-13 EP EP09425101A patent/EP2228054A1/de not_active Withdrawn
-
2010
- 2010-03-02 RU RU2011141422/15A patent/RU2498802C2/ru active
- 2010-03-02 US US13/138,047 patent/US8765150B2/en active Active
- 2010-03-02 SI SI201030130T patent/SI2405890T1/sl unknown
- 2010-03-02 JP JP2011553390A patent/JP5607083B2/ja active Active
- 2010-03-02 MX MX2011008922A patent/MX2011008922A/es active IP Right Grant
- 2010-03-02 EP EP10706234A patent/EP2405890B1/de active Active
- 2010-03-02 DK DK10706234.1T patent/DK2405890T3/da active
- 2010-03-02 WO PCT/EP2010/052598 patent/WO2010102923A2/en active Application Filing
- 2010-03-02 PT PT107062341T patent/PT2405890E/pt unknown
- 2010-03-02 ES ES10706234T patent/ES2400349T3/es active Active
- 2010-03-02 BR BRPI1006418A patent/BRPI1006418A2/pt not_active Application Discontinuation
- 2010-03-02 CN CN2010800108923A patent/CN102341091B/zh active Active
- 2010-03-02 KR KR1020117020162A patent/KR101680175B1/ko active Protection Beyond IP Right Term
- 2010-03-02 CA CA2748856A patent/CA2748856C/en active Active
- 2010-03-02 PL PL10706234T patent/PL2405890T3/pl unknown
- 2010-03-02 PE PE2011001558A patent/PE20120649A1/es active IP Right Grant
-
2011
- 2011-08-24 CO CO11107620A patent/CO6410281A2/es not_active Application Discontinuation
- 2011-09-08 CL CL2011002217A patent/CL2011002217A1/es unknown
-
2012
- 2012-03-14 HK HK12102552.2A patent/HK1161985A1/xx unknown
-
2013
- 2013-01-14 HR HRP20130021AT patent/HRP20130021T1/hr unknown
- 2013-02-14 SM SM201300022T patent/SMT201300022B/xx unknown
- 2013-02-14 CY CY20131100136T patent/CY1113825T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1161985A1 (en) | 2012-08-17 |
| EP2405890A2 (de) | 2012-01-18 |
| PE20120649A1 (es) | 2012-06-07 |
| BRPI1006418A2 (pt) | 2016-11-29 |
| CO6410281A2 (es) | 2012-03-30 |
| WO2010102923A2 (en) | 2010-09-16 |
| CY1113825T1 (el) | 2016-07-27 |
| CA2748856A1 (en) | 2010-09-16 |
| EP2228054A1 (de) | 2010-09-15 |
| CN102341091A (zh) | 2012-02-01 |
| KR101680175B1 (ko) | 2016-11-28 |
| JP2012520254A (ja) | 2012-09-06 |
| CN102341091B (zh) | 2013-08-07 |
| WO2010102923A3 (en) | 2011-03-03 |
| PL2405890T3 (pl) | 2013-04-30 |
| ES2400349T3 (es) | 2013-04-09 |
| RU2498802C2 (ru) | 2013-11-20 |
| RU2011141422A (ru) | 2013-04-20 |
| KR20120003854A (ko) | 2012-01-11 |
| PT2405890E (pt) | 2013-02-20 |
| SI2405890T1 (sl) | 2013-02-28 |
| CL2011002217A1 (es) | 2012-03-09 |
| JP5607083B2 (ja) | 2014-10-15 |
| US20120039953A1 (en) | 2012-02-16 |
| US8765150B2 (en) | 2014-07-01 |
| CA2748856C (en) | 2017-01-03 |
| EP2405890B1 (de) | 2012-11-28 |
| DK2405890T3 (da) | 2013-02-04 |
| MX2011008922A (es) | 2011-12-06 |
| HRP20130021T1 (hr) | 2013-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201300022B (it) | Sospensioni liquide di riluzolo | |
| SMT201600075B (it) | Composto di diamminocarbossammide eterociclica | |
| FR2952993B1 (fr) | Joint filete | |
| FI20095666A0 (fi) | Hitsauksen optimointi | |
| CR10959S (es) | Contenedor | |
| FR2953272B1 (fr) | Joint filete | |
| FR2955119B1 (fr) | Circuit pour liquide biologique | |
| BRPI1008533A2 (pt) | separador de líquidos | |
| BRPI1008744A2 (pt) | hidrotratamento de caboidratos | |
| SMT201600031B (it) | Composti eterociclici di fenossimetile | |
| SMT201500268B (it) | Derivato di 5-idrossipirimidin-4-carbossammide | |
| DK2519512T3 (da) | N1-acyl-5-fluorpyrimidinonderivater | |
| BRPI1008223A2 (pt) | recipiente | |
| BR112012000654A2 (pt) | estruturas de suspensao | |
| FR2952847B3 (fr) | > | |
| FR2958654B1 (fr) | Liquide caloporteur | |
| DK2258907T3 (da) | Lysrør reflektor | |
| DK2269517T3 (da) | Væskeapplikator | |
| DK2440709T3 (da) | Flydende stabiliseringsindretning | |
| ES1071889Y (es) | Envase | |
| TH100792B (th) | ภาชนะของไหล | |
| DE112010000234A5 (de) | Flügelrad-fluidmotor | |
| FI8593U1 (fi) | Puolirunkoseinä | |
| EE00992U1 (et) | Vedelktuste tootmise meetod | |
| UA21638S (uk) | Ємкість для рідини |